Mutation found in drug-resistant fungus

A newly identified genetic mutation in a drug resistant fungus may help in the fight against antimicrobial resistance.

Researchers from the US and the UK found a novel form of resistance to the drug triazole, which is used for invasive aspergillosis, a condition caused by airborne fungus spores.

Professor Jarrod Fortwendel from the University of Tennessee said: โ€œAs with bacteria, antifungal drug resistance is a real challenge facing medicine.

โ€œUnderstanding how the fungus becomes drug resistant is important for designing changes in therapy to overcome aspergillosis.โ€

Invasive aspergillosis is caused by breathing in small airborne spores of the fungus Aspergillus fumigatus. These spores can cause problems in a weakened immune system, following organ transplantation or lung conditions such as asthma or cystic fibrosis. Aspergillosis leads to more than 200,000 life-threatening infections a year.

While resistance to the triazole class of antifungal drugs for treating invasive aspergillosis remains unexplained, the findings may help form a successful approach to tackling antimicrobial resistance.

Professor Dave Rogers, also at Tennessee, added: โ€œIt is very important that the research continues and we find out more about why it is happening and how we can tackle it for the future.โ€

The university teams involved in the research are based Tennessee, Texas and Swansea in the UK. Theyโ€™re working as part of $2 million five-year collaboration funded by the National Institutes of Health in the US.

They detailed the mutations found in triazole-resistant isolates in the American Microbiology Society journal mBio.

700,000 deaths globally per year from a drug-resistant infection: Dr Peter Jackson on AMR at Lab Innovations 2018

Related Content

Pin It on Pinterest

Share This